稳定期高碳酸血症COPD患者家庭启动慢性无创通气:随机对照试验
结果显示家庭启动非劣效于住院启动,两组PaCO2均显著下降且生活质量改善无差异,家庭启动成本显著更低。
要点
- 家庭远程医疗启动慢性NIV在降低日间PaCO2方面非劣效于住院启动。
- 两组6个月时PaCO2均较基线显著下降,生活质量改善无组间差异。
- 家庭启动NIV成本显著低于住院启动,中位费用降低超过50%。
核心结论
- 稳定期高碳酸血症COPD患者经远程医疗在家启动慢性NIV非劣效于住院启动,安全且降低费用超过50%。
主要发现
- 家庭组与住院组6个月PaCO2变化校正均数差为0.04 kPa(95%CI -0.31至0.38 kPa),非劣效界值0.4 kPa。
- 家庭组PaCO2从基线7.3±0.9 kPa降至6.4±0.8 kPa(p<0.001),住院组从7.4±1.0 kPa降至6.4±0.6 kPa(p<0.001)。
- 临床COPD问卷总分变化校正均数差0.0(95%CI -0.4至0.5),组间无差异。
- 家庭启动NIV中位费用€3768(IQR €3546-€4163),住院启动中位费用€8537(IQR €7540-€9175),p<0.001。
临床怎么用
- 对稳定期高碳酸血症COPD患者,可考虑采用远程医疗支持的家庭启动慢性NIV替代住院启动。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Chronic non-invasive ventilation (NIV) has become evidence-based care for stable hypercapnic COPD patients. While the number of patients increases, home initiation of NIV would greatly alleviate the healthcare burden. We hypothesise that home initiation of NIV with the use of telemedicine in stable hypercapnic COPD is non-inferior to in-hospital NIV initiation. METHODS: Sixty-seven stable hypercapnic COPD patients were randomised to initiation of NIV in the hospital or at home using telemedicine. Primary outcome was daytime arterial carbon dioxide pressure (PaCO2) reduction after 6 months NIV, with a non-inferiority margin of 0.4 kPa. Secondary outcomes were health-related quality of life (HRQoL) and costs. RESULTS: Home NIV initiation was non-inferior to in-hospital initiation (adjusted mean difference in PaCO2 change home vs in-hospital: 0.04 kPa (95% CI -0.31 to 0.38 kPa), with both groups showing a PaCO2 reduction at 6 months compared with baseline (home: from 7.3±0.9 to 6.4±0.8 kPa (p<0.001) and in-hospital: from 7.4±1.0 to 6.4±0.6 kPa (p<0.001)). In both groups, HRQoL improved without a difference in change between groups (Clinical COPD Questionnaire total score-adjusted mean difference 0.0 (95% CI -0.4 to 0.5)). Furthermore, home NIV initiation was significantly cheaper (home: median €3768 (IQR €3546-€4163) vs in-hospital: median €8537 (IQR €7540-€9175); p<0.001). DISCUSSION: This is the first study showing that home initiation of chronic NIV in stable hypercapnic COPD patients, with the use of telemedicine, is non-inferior to in-hospital initiation, safe and reduces costs by over 50%. TRIAL REGISTRATION NUMBER: NCT02652559.
引用
- Duiverman ML, Vonk JM, Bladder G, et al. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial. Thorax. 2019. PMID: 31484786. doi:10.1136/thoraxjnl-2019-213303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。